Early research (Phase 1)UnknownNCT06167915
What this trial is testing
Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine (CHO Cell)LYB002V14 in Booster Vaccination
Who this might be right for
SARS-CoV-2COVID-19 Vaccine
Guangzhou Patronus Biotech Co., Ltd. 120